Clinical Trial Update: Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immunosuppressive drugs and gut microbiome effects on pharmacokinetics and microbiome diversity in kidney transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complications of Kidney Transplant
• Immune Suppression Disorders
• Kidney Transplant

Snippet

Sponsor: Oslo University Hospital | Conditions: Kidney Transplant; Complications, Immune Suppression | Phase 4 | Status: ACTIVE_NOT_RECRUITING